These additional new compounds are progressing through a panel of cell-based screening assays which are designed to identify the most potent, druggable compound(s) in the series. The screening is progressing well and it is anticipated that a subset will soon be identified for progression to an animal model of the Covid-19 disease.
The Company has identified its top three anti-SARS-CoV-2 compounds.
These compounds are now progressing through preliminary safety studies as well as bioavailability studies in mice.
Looks like druggable compounds could be ready by mid year phase 1 trial, poorer countries can't vaccinate in time to open up for international travel but we can give you tablet to cure that infection.
- Forums
- ASX - By Stock
- BIT
- Ann: Lead Series for SARS-COV-2 Program
Ann: Lead Series for SARS-COV-2 Program, page-58
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $24.36M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.6¢ | $4.605K | 176.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 499991 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 189421 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 464991 | 0.026 |
8 | 884000 | 0.025 |
2 | 3373333 | 0.024 |
2 | 153913 | 0.023 |
5 | 975000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 189421 | 3 |
0.029 | 305600 | 3 |
0.030 | 47636 | 2 |
0.031 | 159129 | 3 |
0.032 | 500000 | 1 |
Last trade - 12.24pm 20/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |